Results. MSSA BSI decreased from 0.37 per 1,000 hospital days (n = 15) to 0.00 (n = 0), P = 0.0092. All MSSA infections decreased from 0.62 (n = 25) to 0.11 (n = 2), P = 0.0078. Of 694 eligible neonates, 98.8% were screened at least once for MSSA colonization, which was detected in 92 (13.4%) infants. Median weekly prevalence of colonization was 6.7%. Median length of stay of neonates after initial detection of colonization was 30 days. Of colonized neonates, 92% received mupirocin treatment, with a median of 1 course of mupirocin treatment per patient (range, 1-7 courses). Of 54 isolates tested, all were mupirocin-susceptible. In contrast, there was no significant change in the rates of either MRSA (P = 0.71) or Gram-negative (P = 0.45) BSIs. In the comparison NICU, there was no significant change in rate of MSSA BSIs (P = 0.34).
Background. Colonization with Staphylococcus aureus increases the risk of developing healthcare-associated infections (HAIs) in adults, but its role in pediatrics remains unclear. We hypothesized that use of a S. aureus screening and decolonization protocol for pediatric patients undergoing cardiovascular (CV) surgery would result in a reduction of invasive S. aureus infections.
Methods. A S. aureus screening and decolonization protocol (Table 1 ) was implemented for patients undergoing CV surgery at TCH on January 1, 2018. We retrospectively identified and reviewed charts of pediatric patients with S. aureus infections following CV surgery pre-protocol (2017) and post-protocol (January 1, 2018-March 31, 2018). We defined invasive S. aureus infections as: bacteremia, mediastinitis, superficial and deep surgical site infections (SSIs) and ventilator-associated pneumonias (VAPs). A subset of charts were reviewed pre-and post-protocol for methicillin-resistant S. aureus (MRSA) polymerase chain reaction (PCR) result, use of mupirocin and chlorhexidine gluconate (CHG), and choice of intraoperative antibiotic. Data were analyzed with Fisher's exact.
Results. Of 694 pediatric CV surgery patients in 2017, we identified 13 patients with 15 invasive S. aureus infections: bacteremia (5), VAP (4), and SSI (6). Twelve of these infections were caused by methicillin-susceptible S. aureus (MSSA) and 3 were MRSA. The median time to infection was 19 days. In the first 3 month post-protocol period, there were 175 pediatric CV surgery patients with 0 invasive S. aureus infections. Seventy-five charts each were reviewed pre-and post-protocol to assess protocol adherence ( Figure 1 ). Post-protocol MRSA screening peaked at 64%, which increased further to 70% when excluding infants <30 days. Of 40 patients screened with a MRSA PCR, only 1 (2.5%) was positive. Cefazolin use remained high pre-and post-protocol (72/75 vs. 73/75 respectively).
Conclusion. Most pediatric invasive S. aureus infections are caused by MSSA. Following protocol implementation, we observed a decrease in invasive S. aureus infections in CV surgery patients at TCH (P = 0.05), though continued monitoring for protocol compliance and development of S. aureus and other bacterial infections are needed.
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No reported disclosures. Results. We identified 96 (18%) and 23 (4%) neonates with SA colonization and/ or infection on admission. Among the 96 colonized infants, 28 had MRSA and 68 had MSSA. ST59-SCCmecIVa-t437-agr-1 (20/28, 71%) and ST188-t189-agr-1 (11/68, 16%) were the common colonizing MRSA and MSSA clones, respectively. Among 23 isolates associated with infection, 17 were MRSA and ST59-SCCmecIVa-t437-agr-1 (6/17, 35%) was also the most common clone. Of the 119 SA isolates, 108 (91%) contained at least one SAg gene; however, none carried sasX. Cytotoxicity was significantly different among the main clones (P = 0.04). While MRSA and MSSA had similar cytotoxicity (83.7% vs. 85.9%, P = 0.45), infecting isolates had higher cytotoxicity than colonizing isolates (87.6% vs. 84.5%, P < 0.01). Female sex (OR ADJ = 2.05, P < 0.01), age >7 days (OR ADJ = 7.14, P < 0.01), and vaginal delivery (OR ADJ = 2.16, P < 0.01) were RFs for SA colonization, while antibiotic use was protective (OR ADJ = 0.25, P < 0.01).
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Conclusion. SA colonization was common in infants admitted to our NICU and 2 clones predominated. MRSA and MSSA did not differ in cytotoxicity, although infecting isolates had higher cytotoxicity. Several non-modifiable risk factors for SA colonization were identified. Our results suggest that screening infants for SA is useful and interventions to target cytotoxic clones should be explored. 
